A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, acceptability and feasibility of
delivery of Pre-Exposure Prophylaxis (PrEP) or Post-Exposure Prophylaxis) PEP as part of
combination HIV prevention services for high-risk MSM and transgender women.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, Los Angeles
Collaborators:
AIDS Project Los Angeles Los Angeles County Department of Public Health Los Angeles LGBT Center The OASIS Clinic
Treatments:
Emtricitabine Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Tenofovir